4 active warrant series covering 69,369,530 shares (~13.1% potential dilution); nearest expiry 2026-11-15.
| Type | Status | Source | |||||
|---|---|---|---|---|---|---|---|
| warrant | $0.18 | Nov 15, 2026 46d | 21.1M | ITM | 4.0% | C$3.8M | Auto |
| warrant | $0.23 | Nov 15, 2026 46d | 8.8M | ITM | 1.7% | C$2.0M | Auto |
| warrant | $0.22 | Aug 27, 2028 697d | 37.4M | ITM | 7.1% | C$8.2M | Auto |
| warrant | $0.15 | Aug 27, 2028 697d | 2.0M | ITM | 0.4% | C$295K | Auto |
Basis: Current shares & price vs as-filed warrant terms.
8 option grants covering 8,657,000 shares (~1.6% potential dilution). Counted apart from the warrants above.
| Type | Status | Source | |||||
|---|---|---|---|---|---|---|---|
| option | $0.21 | Jan 24, 2027 116d | 900K | ITM | 0.2% | C$189K | Auto |
| option | $0.13 | Oct 19, 2027 384d | 600K | ITM | 0.1% | C$78K | Auto |
| option | $0.22 | Jan 5, 2031 1558d | 250K | ITM | 0.0% | C$55K | Auto |
| option | $0.24 | May 27, 2034 2796d | 1.1M | ITM | 0.2% | C$252K | Auto |
| option | $0.19 | Jun 20, 2034 2820d | 2.3M | ITM | 0.4% | C$437K | Auto |
| option | $0.17 | Aug 27, 2034 2888d | 400K | ITM | 0.1% | C$68K | Auto |
| option | $0.14 | Feb 20, 2035 3065d | 300K | ITM | 0.1% | C$42K | Auto |
| option | $0.18 | Jun 9, 2035 3174d | 2.9M | ITM | 0.5% | C$514K | Auto |
528,799,213 shares outstanding, plus 69,369,530 from warrants and 8,657,000 from options — a fully diluted 606,825,743 shares, or ~14.8% above today's count if every one of them is exercised.
Price history with the company's supply walls overlaid — warrants (amber), employee and consultant options (pink), and free-trading unlock dates (violet). Each wall sits at the price the paper is struck at today, restated through any consolidation, and is measured in the SHARES it can issue rather than the number of certificates. Levels and dates are Pacific Time.
4 active warrant series covering 69,369,530 shares (~13.1% potential dilution); nearest expiry 2026-11-15.
| Type | Status | Source | |||||
|---|---|---|---|---|---|---|---|
| warrant | $0.18 | Nov 15, 2026 46d | 21.1M | ITM | 4.0% | C$3.8M | Auto |
| warrant | $0.23 | Nov 15, 2026 46d | 8.8M | ITM | 1.7% | C$2.0M | Auto |
| warrant | $0.22 | Aug 27, 2028 697d | 37.4M | ITM | 7.1% | C$8.2M | Auto |
| warrant | $0.15 | Aug 27, 2028 697d | 2.0M | ITM | 0.4% | C$295K | Auto |
Basis: Current shares & price vs as-filed warrant terms.
8 option grants covering 8,657,000 shares (~1.6% potential dilution). Counted apart from the warrants above.
| Type | Status | Source | |||||
|---|---|---|---|---|---|---|---|
| option | $0.21 | Jan 24, 2027 116d | 900K | ITM | 0.2% | C$189K | Auto |
| option | $0.13 | Oct 19, 2027 384d | 600K | ITM | 0.1% | C$78K | Auto |
| option | $0.22 | Jan 5, 2031 1558d | 250K | ITM | 0.0% | C$55K | Auto |
| option | $0.24 | May 27, 2034 2796d | 1.1M | ITM | 0.2% | C$252K | Auto |
| option | $0.19 | Jun 20, 2034 2820d | 2.3M | ITM | 0.4% | C$437K | Auto |
| option | $0.17 | Aug 27, 2034 2888d | 400K | ITM | 0.1% | C$68K | Auto |
| option | $0.14 | Feb 20, 2035 3065d | 300K | ITM | 0.1% | C$42K | Auto |
| option | $0.18 | Jun 9, 2035 3174d | 2.9M | ITM | 0.5% | C$514K | Auto |
528,799,213 shares outstanding, plus 69,369,530 from warrants and 8,657,000 from options — a fully diluted 606,825,743 shares, or ~14.8% above today's count if every one of them is exercised.
Price history with the company's supply walls overlaid — warrants (amber), employee and consultant options (pink), and free-trading unlock dates (violet). Each wall sits at the price the paper is struck at today, restated through any consolidation, and is measured in the SHARES it can issue rather than the number of certificates. Levels and dates are Pacific Time.
An issuer that discloses only a plan total appears as one line at its weighted-average exercise price and weighted-average remaining life — the filing's own summary, not a per-grant schedule.
An issuer that discloses only a plan total appears as one line at its weighted-average exercise price and weighted-average remaining life — the filing's own summary, not a per-grant schedule.
